Glycomimetics inc (GLYC)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Operating activities
Net loss

-7,662

-14,726

-13,251

-15,829

-14,083

-13,906

-11,575

-11,278

-11,512

-9,257

-7,950

-8,141

-7,931

-8,328

-7,854

-8,071

-7,554

-8,881

-7,168

10,389

-7,109

-7,393

-6,617

7,991

-5,101

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation

68

67

69

71

70

68

68

69

68

69

70

69

54

50

45

46

47

49

51

46

44

44

40

38

34

Non-cash lease expense

164

160

156

153

149

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation expense

1,822

1,726

1,587

1,519

1,382

1,149

1,171

1,150

1,115

964

962

991

842

726

739

771

727

644

632

458

587

482

441

418

292

Changes in assets and liabilities:
Prepaid expenses and other current assets

-2,267

416

1,608

-527

561

-253

-878

6

182

2,279

513

-194

218

-761

-209

765

241

-276

183

-242

-139

328

-293

162

-1,854

Accounts payable

1,698

28

-1,619

1,195

-832

2,004

-2,580

-614

1,206

995

1,056

72

-1,063

318

-134

-190

1,007

-68

-463

-77

299

290

111

-1,324

652

Accrued expenses

-2,059

465

1,400

1,144

-300

318

1,970

-850

-887

599

156

716

-748

618

-456

555

-3,221

965

565

2,799

-2,637

1,474

1,001

2,275

-292

Noncurrent accrued expenses

393

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities

-191

-98

-183

-176

-171

-

-17

-17

-17

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent

-

-

-

-

-

-

-

-

-

-16

-12

-11

2

-100

41

630

6

57

120

-1

-29

-

-

25

25

Net cash used in operating activities

-3,500

-12,792

-13,448

-11,394

-14,347

-9,980

-10,084

-13,058

-10,208

-8,368

-6,229

-6,107

-9,061

-5,954

-7,472

-7,074

-9,229

-6,957

13,563

-6,143

-8,705

-6,154

-4,753

9,213

-2,587

Investing activities
Purchases of property and equipment

8

12

18

74

39

57

26

25

16

34

32

164

62

438

225

22

17

3

58

204

2

14

102

81

13

Net cash used in investing activities

-8

-12

-18

-74

-39

-57

-26

-25

-16

-34

-32

-164

-62

-438

-225

-22

-17

-3

-58

-204

-2

-14

-102

-81

-13

Financing activities
Proceeds from issuance of common stock, net of issuance costs

-

-

-

-

-

0

0

-208

128,634

19,302

-136

90,737

3,668

1,148

-135

21,350

1,238

-

-

-

-

0

0

-8

57,256

Proceeds from exercise of stock options

129

119

186

75

30

125

504

94

298

152

123

92

5

4

30

2

35

3

20

15

75

-

-

-

-

Net cash provided by financing activities

129

119

186

75

30

125

504

-113

128,932

19,455

-12

90,829

3,673

1,152

-105

21,353

1,274

3

20

15

75

6

0

119

57,256

Net change in cash and cash equivalents

-3,378

-12,685

-13,280

-11,393

-14,356

-9,911

-9,606

-13,197

118,707

11,052

-6,275

84,557

-5,451

-5,240

-7,802

14,255

-7,972

-6,957

13,525

-6,332

-8,632

-6,163

-4,855

9,251

54,655

Non-cash investing and financing activities
Property acquisition costs included in accrued expenses

-

-

-

-

35

-

-

-

-

-

-

-

9

-

-

-

-

-

-

0

10

-

-

-

-

Issuance costs associated with financing included in accrued expenses

-

-

-

-

-

-

-

-

198

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance costs associated with the at-the-market financing included in accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

150

-

-

-

-

-

-

-

-